Abstract
The classical monoamine hypotheses of depressive illness have postulated a deficiency of norepinephrine and/or serotonin at functionally important receptors in the central nervous system (CNS).1,2 An alternative “receptor hypothesis” would explain reduced transmission by a deficiency in signal amplification by the receptor complex. This focus on the receptor gained impetus from studies showing that virtually all effective somatic antidepressant treatment modalities shared the common effect of down-regulation and/or desensitization of β-adrenergic receptor complexes.3,4 Moreover, a significant number of antidepressants down-regulate 5- HT2 (serotonin; 5-hydroxytryptamine) receptors, although, in contrast, electroconvulsive shock up-regulates 5-HT2 receptors.4,5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509–522.
Potter WZ. Psychotherapeutic drugs and biogenic amines: current concepts and therapeutic implications. Drugs 1984; 28: 127–143.
Sulser F, Vetulani J, Mobley PL. Mode of action of antidepressant drugs. Biochem Pharmacol 1978; 27: 257–261.
Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanisms of action of antidepressant treatment. Arch Gen Psychiatry 1981; 38: 1160–1180.
Costain DW, Green AR, Grahame-Smith DG. Enhanced 5-hydroxytryptamine-mediated behavioral responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy. Psychopharmacology 1979; 61: 167–170.
Garcia-Sevilla J A, Zis AP, Hollings worth PJ, et al. Platelet alpha2-adrenergic receptors in major depressive disorders. Arch Gen Psychiatry 1981; 38: 1327–1333.
Wyoh RJ, Murphy DL, Low platelet monoamine oxidase activity and schizophrenia. Schizoph Bull 1976; 2: 77–89.
Mann JJ. Altered platelet monoamine oxidase activity in affective disorders. Psychol Med 1979; 9: 729–736.
Meltzer HY, Arora RC, Bober R, et al. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 1981; 38: 1322–1326.
Kaplan RD, Mann JJ. Altered platelet serotonin uptake in schizophrenia and melancholia. Life Sci 1982; 31: 583–588.
Briley MS, Langer SZ, Raisman R, et al. 3H-Imipramine binding sites are decreased in platelets of untreated depressed patients. Science 1980; 209: 303–305.
Quan-Bui KHL, Plaisant LO, Leboyer M, et al. Reduced platelet serotonin in depression. Psychiatry Res 1984; 13: 129–139.
Mann JJ, Brown RP, Halper JP, et al. Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 1985; 313: 715–720.
McBride PA, Mann JJ, Polley MJ, et al. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets. Life Sci 1987; 40: 1799–1908.
Halper JP, Mann JJ, Brown RP, et al. Blunted beta-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression: isoproterenol dose response studies. Arch Gen Psychiatry 1988; 45: 241–244.
Extein I, Tallman J, Smith CC, et al. Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1979; 1: 191–197.
Wilner PJ, Brown RP, Sweeney JA, et al. Blunted orthostatic response in major depressives. In: New Research Abstracts. 140th Annual Meeting. Chicago: American Psychiatric Association, 1987.
Rudorfer MV, Ross RJ, Linnoila M, et al. Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Arch Gen Psychiatry 1985; 42: 1186–1192.
Mann JJ, Brown RP, Sweeney JA, et al. State-dependent dysregulation of beta-adrenergic responsivity in endogenous depression. In: Abstracts, 25th Annual Meeting American College of Neuropsychopharmacology. Washington, DC, 1986; 187.
Pandey GN, Dysken MW, Garver DL, et al. Beta-adrenergic function in affective illness. Am J Psychiatry 1979; 136: 675–678.
Kafka MS, Siever LJ, Nurnberger JI, et al. Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia. Psychopharmacol Bull 1985; 21: 599–602.
Kronfol Z, House JD, Silva J, et al. Depression, urinary free cortisol excretion and lymphocyte function. Br J Psychiatry 1986; 148: 70–73.
Gormley CJ, Lowry MT, Reder AT, et al. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am J Psychiatry 1985; 142: 1278–1284.
Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216: 1337–1339.
Ferrier IN, McKeith IG, Cross AJ, et al. Postmortem neurochemical studies in depression. Ann NY Acad Sci 1986; 487: 128–142.
Langer G, Heinze G, Reim B, et al. Reduced growth hormone responses to amphetamine in endogenous depressive patients: studies in normal “reactive” and “endogenous” depressive, schizophrenic and chronic alcholic subjects. Arch Gen Psychiatry 1970; 33: 1471–1475.
Checkley SA, Slade AP, Shur E. Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 1981; 138: 51–55.
Pandey GN, Dorus E, David JM, et al. Lithium transport in human red blood cells: genetic and clinical aspects. Arch Gen Psychiatry 1979; 36: 902–908.
Dorus E, Cox NJ, Gibbons RD, et al. Lithium ion transport and affective disorders within families of bipolar patients: identification of a major gene locus. Arch Gen Psychiatry 1983; 40: 545–552.
Cohen J. Statistical approaches to suicidal risk factor analysis. Ann NY Acad Sci 1986; 487: 34–41.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Mann, J.J. et al. (1989). Peripheral Blood Cell Biological Markers in Depression. In: Lerer, B., Gershon, S. (eds) New Directions in Affective Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3524-8_45
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3524-8_45
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96769-1
Online ISBN: 978-1-4612-3524-8
eBook Packages: Springer Book Archive